Search Orphan Drug Designations and Approvals
-
Generic Name: | Antihemophilic factor (recombinant) formulated with sucrose reconstituted with liposome diluent |
---|---|
Date Designated: | 04/29/2009 |
Orphan Designation: | Treatment of hemophilia A |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 09/12/2014 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Bayer HealthCare LLC 555 Whiteplains Road Tarrytown, New York 10591 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-